Lupa Kata Sandi? Klik di Sini

atau Masuk melalui

Belum Memiliki Akun Daftar di Sini


atau Daftar melalui

Sudah Memiliki Akun Masuk di Sini

Konfirmasi Email

Kami telah mengirimkan link aktivasi melalui email ke rudihamdani@gmail.com.

Klik link aktivasi dan dapatkan akses membaca 2 artikel gratis non Laput di koran dan Majalah Tempo

Jika Anda tidak menerima email,
Kirimkan Lagi Sekarang

Govt Plans to Launch Commercialized Vaccine Booster in 2022: Health Minister

Translator

internship

16 September 2021 11:47 WIB

Health Minister Budi Gunadi Sadikin shows the Astrazeneca COVID-19 vaccine during vaccination to Nahdlatul Ulama (NU) clerics at the East Java PWNU Office in Surabaya, East Java, Tuesday, March 23, 2021. Astrazeneca vaccination against 100 young NU kyai is an effort to deal with the COVID pandemic -19 as well as socializing to the public that the Astrazeneca vaccine is safe and lawful. ANTARA PHOTOS / Moch Asim

TEMPO.CO, JakartaHealth Minister Budi Gunadi Sadikin revealed the government's plan to launch a commercialized vaccine booster option in 2022. The vaccine booster is planned to be able to be purchased at pharmacies.

Medically, there is a discussion regarding a difference in understanding between a vaccine booster and a third vaccine.

In August 2021, The Centers for Disease Control and Prevention (CDC) recommended immunocompromised people get a third vaccine.This recommendation arises because people with moderate to severe immune disorders are unable to build sufficient protection despite receiving two doses of the vaccine.

As for other people without immune disorders, so far experts have not recommended getting the vaccine back. Additional vaccines for people without immune disorders are called vaccine boosters. In which, they are still reviewing the administration of a vaccine booster.

Reporting from the Cleveland Clinic's website, pediatrician Michelle Medina explained that the third dose of vaccine is given because the two initial doses of vaccine did not provide enough protection against the Covid-19 virus.

“In a review conducted by the FDA and CDC, people who need a third dose of the Covid-19 vaccine are those who are immunocompromised and people who are on any medication that renders their immune response insufficient to protect against the Covid-19 virus. For these people, two doses of the mRNA vaccine are not sufficient,” Medina wrote.

Meanwhile, Medina explained that the booster vaccine is a vaccine given to people without immune disorders. This vaccine will be given because there is a possibility that the first and second vaccines will decrease in effectiveness over time.

In addition, experts are also concerned that the previous two-dose vaccine may not work well against newer variants, such as the current Delta variant.

The vaccine booster is usually given after a certain amount of time, unlike the third vaccine which is given right after the first two doses of vaccine. The hope is that the immune system will continue to produce antibodies and give it enough time to actually have an adequate immune response.

According to Medina, however, over time the immune system needs a vaccine booster to boost and strengthen the immune response that the body has generated after the initial two doses of injection. Until now, the FDA and CDC are still reviewing the need for a vaccine booster for healthy people.

Read: 34 Percent Healthcare Workers Receive Vaccine Booster

Iqbal Muhtarom | Maudey K. Setyakusuma (Internship)



Thailand to Ban Recreational Cannabis Use by Year-end

57 hari lalu

Thailand to Ban Recreational Cannabis Use by Year-end

Thailand will ban the recreational use of marijuana by the end of this year but continue to allow its use for medical purposes.


Stunting Hinders Indonesia's Chance to Advance, Health Minister Says

18 Oktober 2023

Stunting Hinders Indonesia's Chance to Advance, Health Minister Says

Health Minister Budi Gunadi Sadikin mentioned that stunting would hinder Indonesia's chance to become a developed country.


Health Minister Warns Public on the Hazard of PM2.5 Pollutant

30 Agustus 2023

Health Minister Warns Public on the Hazard of PM2.5 Pollutant

Health Minister Budi Gunadi Sadikin reveals the health hazard of a particulate matter of PM2.5 pollutant.


Indonesian Govt to Cease Covid-19 Funding

22 Agustus 2023

Indonesian Govt to Cease Covid-19 Funding

The government of Indonesia has stopped the special funding for Covid-19 patients.


Health Minister Expects Elon Musk's Internet Provider to be Under US$50

14 Agustus 2023

Health Minister Expects Elon Musk's Internet Provider to be Under US$50

Health Minister said he hopes Elon Musk's internet provider, Starlink, will be installed in community health centers across Indonesia for under US$50.


Health Minister on Mask Mandate: We No Longer Regulate It

14 Maret 2023

Health Minister on Mask Mandate: We No Longer Regulate It

Indonesian Health Minister Budi Gunadi Sadikin states that his side has no longer specifically regulated the use of face masks in public places.


Covid Boosters Still Free But Govt Mulls Options for Paid System

10 Februari 2023

Covid Boosters Still Free But Govt Mulls Options for Paid System

Minister Budi says that the second booster vaccination for adults is still free of charge nationwide.


Minister Responds to Jokowi Not Wearing Mask in Tanah Abang Market

2 Januari 2023

Minister Responds to Jokowi Not Wearing Mask in Tanah Abang Market

President Jokowi appears without a mask when visiting a crowded market in Central Jakarta on Monday, January 2, 2023.


Indonesia Switches Priority from COVID-19 Handling to Health Service Improvement

2 Desember 2022

Indonesia Switches Priority from COVID-19 Handling to Health Service Improvement

Indonesian Health Minister states that the government's priority in the health sector has been shifted from COVID-19 handling to health services.


Health Ministry Says 48% of COVID-19 Deaths Unvaccinated

9 November 2022

Health Ministry Says 48% of COVID-19 Deaths Unvaccinated

Indonesia's COVID-19 case numbers have increased rapidly in the past month.